US bars imports from China's BGI Group over Xinjiang forced-labor allegations
U.S. Customs and Border Protection began enforcing a ban Thursday on shipments from Chinese genomics firm BGI Group and its affiliates BGI Genomics and MGI Tech. The Department of Homeland Security says the companies sourced materials from Xinjiang or worked with regional authorities to recruit and transfer forced labor from Uyghurs and other persecuted groups. China's Commerce Ministry denied the forced-labor claims, calling the move political manipulation and vowing countermeasures.
GoKawiil's interpretation of the reporting above, not reported fact.
The action extends U.S.-China trade friction into biotechnology, a sector the Treasury Department is separately seeking to restrict from receiving American investment. Coming ahead of planned meetings between Xi Jinping and Donald Trump, the ban could complicate diplomatic talks even as it signals Washington's intent to treat genetic technology as a strategic competition front with Beijing.
- CBP's ban on BGI Group, BGI Genomics and MGI Tech took effect Thursday.
- DHS cites alleged forced-labor ties to Xinjiang's Uyghur population as justification.
- China denies the allegations and has threatened unspecified retaliatory measures.
Source: fastcompany.com, 2026-10-29
Published there as: “The Trump administration is now blacklisting this major biotech company and its affiliates. Here’s why”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.